Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

Hangzhou Sciwind Biosciences Co., a pre-commercial biopharmaceutical company focusing on developing innovative therapies to treat metabolic diseases, today announced a licensing and collaboration ...

F45 Training Holdings Inc., a leading global fitness community known for innovative, high-energy group workouts, announced ...

The New Year is a time of reflection and change for many Americans, who start each January with a clean slate and goals for the next 12 months.Many resolutions ...

Digital technologies loom large on the list—from the growing impact of artificial intelligence to the need for tech-enabled ...

Highmark Health President and CEO David Holmberg discussed the uncertainties facing the insurance industry, including the ...

Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things to look for include more widespread adoption of artificial intelligence ...

Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for ...

Their top 10 list includes GLP-1 drugs, salt and sugar reduction and growing use of AI, in the lab and at home.

Prado suggests aiming for 20 to 30 grams of protein per meal (to maximize muscle protein synthesis, the metabolic process by ...

OpenAI CEO Sam Altman and Meta both announced $1 million donations, and Amazon and Apple CEO Tim Cook have also reportedly ...